发明名称 Crystalline forms of febuxostat
摘要 New forms of Febuxostat have bean, prepared and characterized. These forms are useful for examples in the chronic management of hyperuricemia in patients with gout.
申请公布号 US8742129(B2) 申请公布日期 2014.06.03
申请号 US201313782924 申请日期 2013.03.01
申请人 Teva Pharmaceutical Industries Ltd. 发明人 Piran Maytal;Metsger Leonid
分类号 C07D277/56 主分类号 C07D277/56
代理机构 代理人
主权项 1. A crystalline form of Febuxostat, designated Form F10, characterized by data selected from one or more of the following: an X-ray powder diffraction pattern having peaks at 6.7°, 7.7°, 12.8°, 13.3° and 20.0°±0.2°2θ; a solid-state 13C NMR spectrum with signals at 112.7, 125.7, 132.4 and 168.3±0.2 ppm; and a solid-state 13C NMR spectrum having chemical shifts differences between the signal exhibiting the lowest chemical shift and another in the chemical shift range of 100 to 180 ppm of 11.7, 24.7, 31.4 and 67.3±0.1 ppm.
地址 Petach-Tikva IL